(Total Views: 456)
Posted On: 01/25/2021 3:50:56 PM
Post# of 70

$DRRX News Article - DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study of DUR-928 in Severe Alcohol-Associated Hepatitis https://marketwirenews.com/news-releases/dure...72802.html


My Twitter: WhyteStocks